Andrew Peter Walsh
Nessuna posizione attualmente
Profilo
Andrew Peter Walsh served as a Director at Morphogen-IX Ltd.
from 2015 to 2017.
Precedenti posizioni note di Andrew Peter Walsh
| Società | Posizione | Fine |
|---|---|---|
Morphogen-IX Ltd.
 Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Direttore/Membro del Consiglio | 15/05/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Morphogen-IX Ltd.
Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Andrew Peter Walsh
